News and Activities
Hot Off The Press.
Press Releases
Proteocyte Announces Lawrence Murphy as Strategic Advisor Business Development
Toronto, ON; August 5, 2024 – Proteocyte is pleased to announce the appointment of Lawrence Murphy to the role of Strategic Advisor Business Development for both the U.S. and International markets, effective August 1, 2024. As a Senior Executive in the Laboratory Developed Test (LDT) space for...
Proteocyte AI named a Top 10 AI Healthcare Solution Providers of 2024
“With STRATICYTE leading the way, Proteocyte AI is poised to make a profound impact on oral cancer management, providing hope and healing to patients and healthcare professionals around the world.” We are excited to announce that Proteocyte AI is one of the Top 10 AI Healthcare Solution Providers...
Proteocyte Announces Joseph Geraci, Ph.D. as Strategic Advisor, A.I.
Toronto, ON; June 12, 2024 - Proteocyte is pleased to announce the appointment of Joseph Geraci, Ph.D. to the new role of Strategic Advisor, A.I., effective June 3, 2024. Dr. Geraci has a very strong academic and research background which includes a Master of Science in Mathematics from the...
Proteocyte Announces Mark Rood as Key Accounts Director, U.S.
Toronto, ON; June 7, 2024 - Proteocyte is pleased to announce the appointment of Mark Rood as their Director of Key Accounts, USA. Mr. Rood brings over 15 years of experience in the U.S. surgical device industry including the dental surgery market with companies like Henry Schein, NuVasive, and...